These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 20304147
1. Prolonged donor heart preservation with pinacidil: the role of mitochondria and the mitochondrial adenosine triphosphate-sensitive potassium channel. Yang L, Yu T. J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1057-63. PubMed ID: 20304147 [Abstract] [Full Text] [Related]
2. Donor heart preservation with a novel hyperpolarizing solution: superior protection compared with University of Wisconsin solution. Hoenicke EM, Sun X, Strange RG, Damiano RJ. J Thorac Cardiovasc Surg; 2000 Oct; 120(4):746-54. PubMed ID: 11003758 [Abstract] [Full Text] [Related]
3. Protective effects of pinacidil hyperpolarizing cardioplegia on myocardial ischemia reperfusion injury by mitochondrial KATP channels. Yu T, Fu XY, Liu XK, Yu ZH. Chin Med J (Engl); 2011 Dec; 124(24):4205-10. PubMed ID: 22340388 [Abstract] [Full Text] [Related]
4. Donor heart preservation with pinacidil: the role of the mitochondrial K ATP channel. Diodato MD, Shah NR, Prasad SM, Gaynor SL, Lawton JS, Damiano RJ. Ann Thorac Surg; 2004 Aug; 78(2):620-6; discussion 626-7. PubMed ID: 15276534 [Abstract] [Full Text] [Related]
6. Kidney transplantation from non-heart-beating donors after oxygenated low-flow machine perfusion preservation with histidine-tryptophan-ketoglutarate solution. Minor T, Sitzia M, Dombrowski F. Transpl Int; 2005 Jan; 17(11):707-12. PubMed ID: 15717215 [Abstract] [Full Text] [Related]
7. Progress towards a more physiologic approach to donor heart preservation: the advantages of hyperpolarized arrest. Diodato MD, Shah NR, Prasad SM, Racen EL, Mizutani S, Lawton JS, Damiano RJ. J Heart Lung Transplant; 2005 Sep; 24(9):1362-8. PubMed ID: 16143258 [Abstract] [Full Text] [Related]
8. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery. Karck M, Vivi A, Tassini M, Schwalb H, Askenasy N, Navon G, Borman JB, Uretzky G. J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717 [Abstract] [Full Text] [Related]
9. Improved myocardial function with the addition of pinacidil to custadiol. Ikizler M, Dernek S, Sevin B, Maxey TS, Kural T. Transplantation; 2002 Dec 27; 74(12):1666-71. PubMed ID: 12499877 [Abstract] [Full Text] [Related]
10. Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. Lee S, Huang CS, Kawamura T, Shigemura N, Stolz DB, Billiar TR, Luketich JD, Nakao A, Toyoda Y. Surgery; 2010 Aug 27; 148(2):463-73. PubMed ID: 20627336 [Abstract] [Full Text] [Related]
11. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation. Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Cullen J, Lansing K, Bozorgzadeh A. Exp Clin Transplant; 2006 Jun 27; 4(1):451-7. PubMed ID: 16827642 [Abstract] [Full Text] [Related]
12. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB]. Yu T, Liu X, Yu Z, Yang S, Ye Y, Yang X, Gao Z. Zhonghua Wai Ke Za Zhi; 2000 Dec 27; 38(12):931-4. PubMed ID: 11832201 [Abstract] [Full Text] [Related]
13. [The protective effect of diazoxide on long-term heart preservation]. Guo W, Shen YL, Chen YY, Hu ZB, Yan ZK, Xia Q. Sheng Li Xue Bao; 2004 Oct 25; 56(5):632-8. PubMed ID: 15497046 [Abstract] [Full Text] [Related]
14. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium. Pomerantz BJ, Robinson TN, Morrell TD, Heimbach JK, Banerjee A, Harken AH. J Thorac Cardiovasc Surg; 2000 Aug 25; 120(2):387-92. PubMed ID: 10917958 [Abstract] [Full Text] [Related]
15. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants? Kevelaitis E, Oubénaissa A, Mouas C, Peynet J, Menasché P. J Thorac Cardiovasc Surg; 2001 Jan 25; 121(1):155-62. PubMed ID: 11135172 [Abstract] [Full Text] [Related]
16. Endothelial dysfunction after long-term cold storage in HTK organ preservation solutions: effects of iron chelators and N-alpha-acetyl-L-histidine. Radovits T, Lin LN, Zotkina J, Koch A, Rauen U, Köhler G, Karck M, Szabó G. J Heart Lung Transplant; 2008 Feb 25; 27(2):208-16. PubMed ID: 18267229 [Abstract] [Full Text] [Related]
17. Total recovery of heart grafts of non-heart-beating donors after 3 hours of hypothermic coronary oxygen persufflation preservation in an orthotopic pig transplantation model. Yotsumoto G, Jeschkeit-Schubbert S, Funcke C, Kuhn-Régnier F, Fischer JH. Transplantation; 2003 Mar 27; 75(6):750-6. PubMed ID: 12660496 [Abstract] [Full Text] [Related]
18. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors? Lee S, Huang CS, Kawamura T, Shigemura N, Billiar TR, Nakao A, Toyoda Y. Ann Thorac Surg; 2011 Mar 27; 91(3):755-63. PubMed ID: 21352993 [Abstract] [Full Text] [Related]
19. Myocardial protective effect of urethane on isolated rat hearts in prolonged hypothermic preservation. Jin Z, Wu T, Bi S, Zhou H, Cui Q, Zhou J, Kang X, Yi D, Liu W. Heart Surg Forum; 2009 Dec 27; 12(6):E316-9. PubMed ID: 20037096 [Abstract] [Full Text] [Related]
20. Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study. Pritzwald-Stegmann P, Hoyer A, Kempfert J, Dhein S, Mohr FW. Pharmacology; 2011 Dec 27; 88(3-4):167-73. PubMed ID: 21952163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]